Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study - sprookjes - yvandenbroek - TriplyDB

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

http://www.wikidata.org/entity/Q30368624

about

Molecular Pathogenesis of NASH Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter Genetic predisposition in nonalcoholic fatty liver disease.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.The Association between Pediatric NAFLD and Common Genetic Variants.Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.The intersection of nonalcoholic fatty liver disease and obesity.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Genetic and hormonal control of hepatic steatosis in female and male mice.Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.Editorial: A New Spin on Magnetic Resonance Elastography.Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Letter: Mendelian randomisation to investigate moderate alcohol consumption in nonalcoholic fatty liver disease; modest effects need large numbers-authors' reply.Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.Associations of adult genetic risk scores for adiposity with childhood abdominal, liver and pericardial fat assessed by magnetic resonance imaging.Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action.Systems Genetics of Liver Fibrosis.Pediatric Non-alcoholic Fatty Liver Disease.

P2860

Q28071265-27353D11-0AB9-4DC1-BE0D-5FA40AB98C4F Q28831365-6ECADD80-29AA-49EE-97A4-F7BE0BA51776 Q30235398-651DD8EB-7DA7-4A2E-97BD-3E966F5272C9 Q30355082-268B799F-B99C-4204-9249-2B717806261E Q30364476-B7D878C8-4CE9-4D20-A526-C58B81E4BAE5 Q30366572-E45AA101-2C2C-4D1F-88B5-A171CAE250E1 Q31134971-24AF669C-5CC3-4E11-8D75-7D32BDFF9A0F Q33831722-F7AD2EFF-6A27-44EC-8629-95CB86015338 Q36569181-E0B17DC0-7764-45B0-8DA0-3B6674B4DBBB Q36833028-4C475404-5094-4709-A572-24AF3C638462 Q37087800-FF0D8CAE-749C-45EE-88BF-3E6762AE0D07 Q37173770-DF143DCC-7812-4540-A9EE-958899BD892F Q38607460-39883D8F-8594-4F02-8FC4-CD58BBD2ECD9 Q38668329-D3474BA0-7F2C-47ED-9CEC-1F7782DC2923 Q38676257-5D8E5CF1-035C-4D99-A913-39DADF2B0911 Q38714560-FB34421C-42EC-46BC-AD2B-D9C99C2F5A5B Q38752520-92B51B6A-8314-41F9-A167-90B0606A0A96 Q38798845-A2467695-F080-4E29-ABBA-A3248AA6C072 Q38806840-7ED60D19-43DB-4234-9563-599D45FD99B0 Q39177106-2C3EBED1-F260-4E35-B143-EFB637B56C72 Q40154653-1A4ECA74-41F2-4F51-9470-D473A8A33626 Q40367115-FD1B8EEC-D4B2-4B57-B66C-215213C29749 Q40444861-49724CAF-7BC5-4C01-881E-1E2416CAC2DE Q40528724-CBD93E17-8BC2-443E-A3AE-5A061611EEE2 Q40724577-4B69BD2A-5589-4D01-B3FB-A101EABDDBE8 Q40766803-706DCB17-8D3D-4319-8E24-7E67548852D7 Q41388809-6B648721-0D2A-4FAC-92B1-553953464E61 Q45067817-8DCF5F3E-AD11-47EE-B94C-A27FA9975994 Q45942296-36EAEA5A-7A79-4AC6-B166-5A6E3422BBB0 Q45988395-F45FD027-E2D3-40E9-948F-6AEE406B75F5 Q46617785-4ACACF2C-77CA-4C10-8A5F-8486A861AB0D Q47546971-72B9C2A2-0D5B-405E-B1AA-6EB05A985D2B Q47713893-8F8A7D21-66D4-4A52-8107-C8FE40A52C8E Q47880294-6B07EC54-247B-4ABB-B23E-E56D12B9C8E5 Q48125567-1DD02332-C7C7-4AE0-8CE7-36D37EE3558D Q48187865-ECA97915-5999-4C17-8D39-2E5A61618A85 Q50045867-98906CA5-8AEE-47E5-A8F7-741F47C6148A Q51271391-55136857-2A0D-4A65-89B6-1A8F7C41092A Q52946378-405EB1A2-ABE4-4D7E-843A-691ADFC1615F Q53120583-FA926F5C-B75D-46DF-AAE7-B9AB1BFBA812

P2860

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

http://www.wikidata.org/entity/Q30368624

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@ast

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@en

type

label

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@ast

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@en

prefLabel

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@ast

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@en

P1433

Q30368624-8E61EBFF-FB6A-4929-9D5D-C97A6892E73B

P1476

Q30368624-01F8B068-BAFA-4E88-9CD5-15022E0D8612

P2093

Q30368624-002EEA3B-8A6F-45FD-B820-0AFEB60C24D0

Q30368624-09954833-5AEA-4D5F-94D1-39F74949B8D4

Q30368624-11967EE8-9617-4B3E-9A80-4C9DE1D4B355

Q30368624-1E386DFE-BDAF-426E-B642-6462DC9AEFAA

Q30368624-36D62FF5-7A67-4B90-98C2-2FBF29F8FBAE

Q30368624-3CEE8107-E150-491B-8876-1B916010FC78

Q30368624-46E899B8-9EC7-4F74-B3E5-7743582E07B5

Q30368624-82593624-226D-41E1-B00A-9E5F60DB5D76

Q30368624-98B09674-0178-486E-B5D0-76911D21DD4B

Q30368624-9F344DBC-790D-4BA3-AD3B-0BE7D8D638EA

P2860

Q30368624-004B1EEF-BBC8-4BD1-AED0-E22D582A5AA6

Q30368624-02AFB0B0-42A0-4171-B683-9C55D5E4656A

Q30368624-078397BC-1433-431A-B9F5-84F224F320F1

Q30368624-07B8D480-7E4F-4252-A8FC-6A8701F2B95E

Q30368624-0AB9D07A-8B88-4CD6-BDFF-A17676AB9BDE

Q30368624-0E87F67C-4004-428B-8907-F21845F4865D

Q30368624-0EDABB75-2171-4CD7-977E-96D7AD3BFE68

Q30368624-1370B0DF-622B-4333-AF38-7DF8AAF100A3

Q30368624-13BCC628-5292-4B57-9579-713258063FA3

Q30368624-14E62CF9-128E-4505-9607-1AB335D7D530

P304

Q30368624-11A5E79B-4052-4F39-B7C7-BA8CD3DE6D15

P31

Q30368624-64491A1C-F440-40F9-844A-541A3A0F2022

P356

Q30368624-E06B14FA-32B4-4D9B-BF78-7DCF92CFBC33

P407

Q30368624-2C3D4288-C141-48DD-9B71-B9E648E1DBFE

P433

Q30368624-23E2AD45-5C6E-457F-B8B4-019F11AD6642

P478

Q30368624-DD24869A-C5B5-4F78-90AB-48E1F82B8238

P50

Q30368624-B76F79EF-AAF7-4722-A1F7-DE131D683CDA

P577

Q30368624-AD8844A0-E6D7-4A78-A0F5-61834813CAC1

P698

Q30368624-897952DB-D67D-4D16-BAED-F5413230103E

P921

Q30368624-4B2FADB7-A5B9-490C-9998-1D0E70A3C11E

P932

Q30368624-0813B729-A269-4A32-8232-499DD8DF706E

P356

J.GASTRO.2015.08.011

P1433

Gastroenterology

P1476

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

@en

P2093

Ana Bhatt

http://www.w3.org/2001/XMLSchema#string

Brandon Ang

http://www.w3.org/2001/XMLSchema#string

Carolyn Hernandez

http://www.w3.org/2001/XMLSchema#string

Chi-Hua Chen

http://www.w3.org/2001/XMLSchema#string

Claude B Sirlin

http://www.w3.org/2001/XMLSchema#string

Ekihiro Seki

http://www.w3.org/2001/XMLSchema#string

Genetics of NAFLD in Twins Consortium

http://www.w3.org/2001/XMLSchema#string

Joanie Salotti

http://www.w3.org/2001/XMLSchema#string

Karen E Nelson

http://www.w3.org/2001/XMLSchema#string

Lisa Richards

http://www.w3.org/2001/XMLSchema#string

P2860

Magnetic resonance elastography of liver: technique, analysis, and clinical applications.

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

Controversies in the Diagnosis and Management of NAFLD and NASH.

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

P304

1784-1793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2015.08.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P50

David A. Brenner

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26299412

http://www.w3.org/2001/XMLSchema#string

P921

P932

4663110

http://www.w3.org/2001/XMLSchema#string